Clinical Trial Update: A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical study evaluating HRS-6209 in combination with other treatment regimens for breast cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HRS-6209 (HRS-6209)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING